GlassScriptPhysician profile
Melissa G Kulp
NPI 1003232489
$2,836.46
in general payments reported to CMS, 2019-2025
17 companies · $1,118 in 2025
The $1,118 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.03 · 2022: $151 · 2023: $886 · 2024: $660 · 2025: $1,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,489 · Consulting Fee: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,488.62 |
| Consulting Fee | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $939.29 | 2022-2025 | |
| Amgen INC. | $329.53 | 2022-2025 | Prolia, Evenity, Prolia |
| Boston Scientific Corporation | $302.49 | 2024-2025 | Intracept, General - Pain Management |
| Medtronic, INC. | $302.13 | 2023-2024 | Intellis Adaptivestim, Vanta Adaptivestim |
| Collegium Pharmaceutical, INC. | $254.94 | 2023-2025 | Belbuca, Xtampza |
| Janssen Pharmaceuticals, INC | $151.30 | 2023-2025 | Spravato, Invega Sustenna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $133.50 | 2023-2024 | Caplyta |
| Vertos Medical, INC. | $115.80 | 2023 | Mild Device Kit |
| Exact Sciences Corporation | $93.93 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $41.00 | 2024-2025 | Mounjaro, Zepbound |
| Almatica Pharma LLC | $39.76 | 2022-2023 | Loreev Xr |
| Alkermes, INC. | $33.15 | 2022-2024 | Aristada, Lybalvi |
| Novo Nordisk INC | $32.17 | 2025 | Wegovy |
| Biogen, INC. | $22.03 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.42 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.55 | 2024 | |
| Gilead Sciences, INC. | $14.47 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Kulp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.